• Publications
  • Influence
Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
TLDR
Despite lower CVF concentrations of key HAART components, such as efavirenz and lopinavir, virologic rebound was rare and may have implications for the prevention of sexual transmission during HAART and for pre-exposure or postexposure prophylaxis. Expand
Detection of Fastidious Vaginal Bacteria in Women with HIV Infection and Bacterial Vaginosis
TLDR
Fastidious bacteria (BVAB 1, 2, and 3) remain specific indicators of BV in HIV-infected women, and BVAB2 may contribute to the elevated vaginal pH that is a hallmark of this syndrome. Expand
A success story: HIV prevention for injection drug users in Rhode Island
TLDR
There has been a greater decline in IDU-related new HIV diagnoses in Rhode Island compared to national data reported by the Centers for Disease Control and Prevention, and it is hypothesize that this dramatic decline is related to extensive HIV prevention efforts targeting IDUs. Expand
Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study.
TLDR
The current study demonstrates that the prevalence of HIV genital tract shedding is low among women on HAART with a diagnosis of asymptomatic BV, and is consistent with the few related studies that assessed the impact of STI treatment on HIV-1 viral load. Expand